TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Call Transcript May 15, 2025
TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.2.
, IR: Mary Szela – President and CEO James Young – CFO Richard Marshall – Medical Director
Operator: Good morning and welcome to TriSalus Life Sciences First Quarter 2025 Earnings Conference Call. Currently, all participants are on a listen-only mode. We will be facilitating a...
